World Health Organisation: International Agency for Research on Cancer. GLOBOCAN. Cancer incidence and mortality worldwide in. 2008, http://globocan.iarc.fr/,
National Cancer Institute Surveillance Epidemiology and End Results: SEER Stats Facts Sheets. Colon and rectum cancer survival and stage. http://seer.cancer.gov/statfacts/html/colorect.html,
Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000, 343: 1603-1607. 10.1056/NEJM200011303432203.
Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993, 329: 1977-1981. 10.1056/NEJM199312303292701.
Ananda SS, McLaughlin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, Steel MCA, Jones IT, Hastie IA, Rieger NA, Shedda S, Compston DJ, Gibbs P: Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust. 2009, 191: 378-381.
Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM: Randomised controlled trial of fecal occult blood screening for colorectal cancer. Lancet. 1996, 348: 1472-1477. 10.1016/S0140-6736(96)03386-7.
Australian Cancer Network Colorectal Cancer Guidelines Revision Committee: Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp106_0.pdf,
National Bowel Cancer Screening Program - information for the public. http://www.medicareaustralia.gov.au/public/services/nbcsp/index.jsp,
Australian Institute of Health & Welfare & Australian Government Department of Health Ageing: National Bowel Cancer Screening Program: annual monitoring report 2009 data and data supplement 2010. 2010, Canberra: AIHW, Cancer Series no.57. Cat. No. CAN 53
Pignone M, Flitcroft KL, Howard K, Trevana LJ, Salkeld GP, St John J: Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Med J Aust. 2010, 194: 180-185.
Australian Institute of Health & Welfare & Australian Government Department of Health Ageing: National Bowel Cancer Screening Program: annual monitoring report 2009. 2009, Canberra: AIHW, Cancer series no. 49. Cat. no. CAN 45
Australian Institute of Health & Welfare & Australian Government Department of Health Ageing: National Bowel Cancer Screening Program monitoring report 2007. 2008, Canberra: AIHW, Cancer series no. 40. Cat. no. CAN 35
Australian Institute of Health & Welfare & Australian Government Department of Health Ageing: National Bowel Cancer Screening Program monitoring report 2008. 2008, Canberra: AIHW, Cancer series 44. Cat. no. 40
Weller D, Coleman D, Robertson R, Butler P, Melia J, Campbell C, Parker R, Patnick J, Moss S: The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007, 97: 1601-1605. 10.1038/sj.bjc.6604089.
Malila N, Oivanen T, Malminiemi O, Hakama M: Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ. 2008, 337: 3371-3375.
Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J: Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Aust N Z J Public Health. 2002, 26: 236-241. 10.1111/j.1467-842X.2002.tb00680.x.
Thomas RJ, Clarke VA: Colorectal cancer: a survey of community beliefs and behaviours in Victoria. Med J Aust. 1998, 169: 37-40.
Weller DP, Owen N, Hiller JE, Willson K, Wilson D: Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health. 1995, 19: 19-23.
Weber MF, Banks E, Ward R, Sitas F: Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. J Med Screen. 2008, 15: 137-142. 10.1258/jms.2008.008050.
Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN: Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010, 50: 3-10. 10.1016/j.ypmed.2009.12.005.
McCaffery K, Wardle J, Nadel M, Atkin W: Socioeconomic variation in participation in colorectal cancer screening. J Med Screen. 2002, 9: 104-108. 10.1136/jms.9.3.104.
Rees G, Martin PR, Macrae FA: Screening particpation in individuals with a family history of colorectal cancer: a review. Eur J Cancer Care. 2007, 17: 221-232.
Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ: Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004, 100: 2093-2103. 10.1002/cncr.20276.
Subramanian S, Klosterman BA, Amonkar MM, Hunt TL: Adherence with colorectal cancer guidelines: a review. Prev Med. 2004, 38: 536-540. 10.1016/j.ypmed.2003.12.011.
Wardle J, Miles A, Atkin W: Gender difference in utilization of colorectal cancer screening. J Med Screen. 2005, 12: 20-27. 10.1258/0969141053279158.
Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R: Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002, 23: 28-35. 10.1016/S0749-3797(02)00444-0.
Duncan A, Wilson C, Cole SR, Mikocka-Walus A, Turnbull D, Young GP: Demographic associations with stage of readiness to screen for colorectal cancer. Health Promotion Journal of Australia. 2009, 20: 7-12.
Koo JH, Arasaratnam MM, Liu K, Redmond DM, Connor SJ, Sung JJY, Leong RWL: Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population. Cancer Epidemiol. 2010, 34: 604-610. 10.1016/j.canep.2010.05.013.
Dillman DA: Mail and Telephone Surveys: The Total Design Method. 1978, New York: John Wiley & Sons
McEvoy M, Smith W, D'Este C, Duke J, Peel R, Schofield P, Scott R, Byles J, Henry D, Ewald B, Hancock S, Smith D, Attia J: Cohort profile: The Hunter Community Study. Int J Epidemiol. 2010, 39: 1452-1463. 10.1093/ije/dyp343.
Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae F, Attia J, McEvoy M: Current state of medical-advice-seeking behaviour for symptoms of colorectal cancer: determinants of failure and delay in medical consultation. Col Dis. 2012, 14: 222-229. 10.1111/j.1463-1318.2012.02881.x.
Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Attia J, McEvoy M: Factors associated with consultation behaviour for primary symptoms potentially indicating colorectal cancer: A cross-sectional study on response to symptoms. BMC Gastroenterol. 2012, 12: 100-10.1186/1471-230X-12-100.
Cole SR, Young GP, Byrne D, Guy JR, Morcom J: Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen. 2002, 9: 147-152. 10.1136/jms.9.4.147.
Zajac IT, Whibley AH, Cole SR, Byrne D, Guy J, Morcom J, Young GP: Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. J Med Screen. 2010, 17: 19-24. 10.1258/jms.2010.009101.
Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Shekelle PG: Interventions that increase the use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002, 136: 641-651.
Ellerbeck EF, Engelman KK, Gladden J, Mosier MC, Raju GS, Ahluwalia JS: Direct observation of counselling on colorectal cancer in rural primary care practices. J Gen Intern Med. 2001, 16: 697-700. 10.1111/j.1525-1497.2001.01224.x.
Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML: Health plan policies and programs for colorectal cancer screening: a national profile. Am J Manag Care. 2004, 10: 273-279.
Kelly KM, Sweet K: In search of a familial cancer risk assessment tool. Clin Genet. 2007, 71: 76-83.
Westman J, Hampel H, Bradley T: Efficacy of touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 2000, 37: 354-360. 10.1136/jmg.37.5.354.
Ioannou GN, Chapko MK, Dominitz JA: Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003, 98: 2082-2091. 10.1111/j.1572-0241.2003.07574.x.
Sewitch MJ, Fournier C, Ciampi A, Dyachenko A: Colorectal cancer screening in Canada: Results of a national survey. Chronic Dis Can. 2008, 29: 9-21.
Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, Cole S, Jiwa M, Tsourtos G, Martini A, Gill T, Baratiny G, Matt MA: How equitable are colorectal cancer screening programs which include FOBTs? A review of the qualitative and quantitiative studies. Prev Med. 2010, 50: 165-172. 10.1016/j.ypmed.2010.02.003.
Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L: Adherence to continuous screening for colorectal neoplasia. Med Care. 1993, 31: 508-519. 10.1097/00005650-199306000-00004.
Pignone M, Bucholtz D, Harris R: Patient preferences for colon cancer screening. J Gen Intern Med. 1999, 14: 432-437. 10.1046/j.1525-1497.1999.00018.x.
Ward PR, Javanparast S, Ah Matt M, Martini A, Tsourtos G: Equity of colorectal cancer screening: a cross-sectional anlaysis of National Bowel Cancer Screening Program data for South Australia. Aust N Z J Public Health. 2010, 35: 61-65.
von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S, Wardle J: Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer. 2009, 101: 60-63.
Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L: Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ. 2004, 171: 461-465. 10.1503/cmaj.1031921.
Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML: Trends in colorectal cancer test use in the medicare population, 1998–2005. Am J Prev Med. 2009, 37: 1-7. 10.1016/j.amepre.2009.03.009.
O'Malley AS, Forrest CB, Feng S, Mandelblatt J: Disparities despite coverage. Gaps in colorectal cancer screening among medicare beneficiaries. Arch Intern Med. 2005, 165: 2129-2135. 10.1001/archinte.165.18.2129.
Dixon A, Legrand J, Henderson J, Murray R, Poteliakhoff E: Is the NHS equitable? A review of evidence. http://www.erpho.org.uk/viewResource.aspx?id=8772,
Ulin PR, Robinson ET, Tolley EE: Qualititative methods in public health. 2005, San Francisco, CA: Jossey-Boss
Fishbein M: Developing effective behavior change interventions: some lessons learned from behavioral research. 1995, Rockville, MD: National Institutes of Health
Matthews BA, Anderson RC, Nattinger AB: Colorectal cancer screening behavior and health insurance status. Cancer Cause Control. 2005, 16: 735-742. 10.1007/s10552-005-1228-z.
Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D: Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000, 9: 229-232.
Khoja S, McGregor ES, Hilsden RJ: Validation of self-reported history of colorectal cancer screening. Can Fam Physician. 2007, 53: 1192-1197.
Rauscher GH, Johnson TP, Cho YL, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 748-757. 10.1158/1055-9965.EPI-07-2629.
Partin MR, Grill J, Noorbaloochi S, Powell A, Burgess DJ, Vernon SW, Halek K, Griffin JM, van Ryn M, Fisher DA: Validation of self-reported colorectal cancer screening behaviour from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev. 2008, 17: 768-776. 10.1158/1055-9965.EPI-07-0759.
Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW: Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Cancer Epidemiol Biomarkers Prev. 2008, 17: 777-784. 10.1158/1055-9965.EPI-07-0441.
Ziogas A, Anton-Culver H: Validation of family history data in cancer family registries. Am J Prev Med. 2003, 24: 190-198. 10.1016/S0749-3797(02)00593-7.
Murff HJ, Spigel DR, Syngal S: Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004, 292: 1480-1489. 10.1001/jama.292.12.1480.
Mitchell RJ, Brewster D, Campbell H, Porteous MEM, Wyllie AH, Bird CC, Dunlop G: Accuracy of family history of colorectal cancer. Gut. 2008, 53: 291-295.
Whittingham MJ, Stephens PA, Bradbury RB, Freckelton RP: Why do we still use stepwise modelling in ecology and behaviour?. J Anim Ecol. 2006, 75: 1182-1189. 10.1111/j.1365-2656.2006.01141.x.
Soledad Cepeda M, Boston R, Farrar JT, Strom BL: Comparison of logistic regression versus propensity score when the number of events is low and there a multiple confounders. Am Epidemiol. 2003, 158: 280-287. 10.1093/aje/kwg115.
Rutter C, Virgina F, Lachenbruch P: Bias in error rate estimates in discriminant analysis when stepwise variable selection is employed. Commun Stat Simulat. 1991, 20: 1-22. 10.1080/03610919108812935.
Derksen S, Keselman HJ: Backward, forward and stepwise automated subset selection algoritms: Frequency of obtaining authentic and noise variables. Brit J Math Stat Psy. 1992, 45: 265-282. 10.1111/j.2044-8317.1992.tb00992.x.
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993, 328: 1365-1371. 10.1056/NEJM199305133281901.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996, 348: 1467-1471. 10.1016/S0140-6736(96)03430-7.
Cancer Council Australia: Cancer Council Australia pre-budget submission. 2011, http://www.cancer.org.au/policy/submissionstogovernment/Cancer_Council_Australia_pre-budget_submission_2011-2012.htm, –12. Bowel cancer screening: program expansion would reduce Medicare and PBS costs - and save lives,